Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma
暂无分享,去创建一个
J. Earle | L. Kvols | D. Trump | R. Hahn | P. Carbone | P. Elson | T. E. Davis | D. Glover | S. Vogl